Skip to content

Search

Please use this search facility to search all content found within the website:

Search words under length of 4 characters are not processed.

290 results:

The 23rd annual meeting of the Scottish Cardiovascular Forum

The 23rd annual meeting of the Scottish Cardiovascular Forum

The 23rd annual Scottish Cardiovascular Forum (SCF) meeting took place at the Strathclyde Institute of Pharmacy and Biomedical Sciences (University of Strathclyde, Glasgow) on Saturday 1 February

Pharmacology? What’s that? OK, I’ll try the University College Dublin summer school!

As the British Pharmacological Society’s Ambassador for Ireland, one of my key advocacy and outreach activities is hosting the annual University College Dublin (UCD) Inherited Blindness Summer

Your Society

Creating your networks You may be aware that we have been reviewing the effectiveness of our Affinity Groups and how we can better support valuable connections and collaboration between our

The Future of Safe Prescribing 

A joint one-day conference between the British Pharmacological Society and the Royal College of Physicians Ireland was held in Dublin on 29 March. This conference was designed to

Linking the Life Sciences

The Life Sciences Post-Translational Modifications and Cell Signalling meeting, which took place 17-18 March 2019 at the East Midlands Conference Centre

Diversity and inclusion in research: beyond the researcher

Biomedical, medical and health research needs to represent the diversity of the population to be truly beneficial for everyone.

Welcome to the new BPS website!

Welcome to the new BPS website!

You might have noticed things look a little different around here. We are pleased to welcome you to our newly redeveloped BPS website!

Adam Cohen

Prof. Adam Cohen, professor of clinical pharmacology, Centre for Human Drug Research, Leiden, Netherlands What do you do? and what is a typical week for you?What do you do? and what is a

The CERSI-PGx Initiative – A New Chapter for BPS – Part 2 & 3

The CERSI-PGx Initiative – A New Chapter for BPS – Part 2 & 3

Part 2: PGx is the study of how genetic variations influence a person’s response to medicines, being efficacy or safety. The goal of CERSI-PGx, led by Sir Munir Pirmohamed, is to enable PGx

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

The British Journal of Pharmacology (BJP) has published its mini-review of ‘Novel drugs approved by the EMA, the FDA and the MHRA in 2025’. This is the third yearly mini-review that the journal has